Method and kit for cytokine analysis from a human whole blood sample
US10161936B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Mar 7, 2014 |
| Grant date | Dec 25, 2018 |
| Priority date | — |
| Expiry date | Mar 7, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to a method for prognostic evaluation of the disease progression of rheumatoid arthritis, in particular prognostic evaluation of the disease progression during treatment, and for the diagnosis and/or activity determination of rheumatoid arthritis by analysing cytokines from a human full blood sample. In the method according to the invention, a volume of a full blood sample of a human is transferred into at least one test tube containing a stimulating agent. As control samples, the same volume of a full blood sample of the human in each case is transferred into an empty test tube as a negative control and a test tube containing lipopolysaccharide as a positive control respectively. After incubation, the concentration of at least one proinflammatory cytokine is determined from the cell-free residue of each test tube. By way of an altered concentration of the at least one cytokine in the at least one test tube comprising the stimulating agent, the prognostic evaluation of the disease progression or the diagnosis is subsequently made.The invention further relates to an associated diagnostic kit and to the use thereof. The invention is applied in medical diagnostic…
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.